Synapse

← BMJ

Papers in BMJ

Page 11 · newest first

  1. Ignoring deaths, benefiting polluters: EPA discards science on pollution harmsBMJ · 2026
  2. When I use a word . . . Artificial intelligence—predicting and detecting adverse drug reactionsBMJ · 2026
  3. “Technostress”—the NHS is overloading doctors with devicesBMJ · 2026
  4. Ketamine: reclassification alone will not reduce harmsBMJ · 2026
  5. Why clinical trials are leaving the US—and Asia and Australia are welcoming themBMJ · 2026
  6. India has overtaken the US on clinical trials but struggles with regulationBMJ · 2026
  7. How China became the new world leader in clinical trialsBMJ · 2026
  8. Medicaid: the medical safety net of the United States is being unraveledBMJ · 2026
  9. Trachoma: the final push for global eliminationBMJ · 2026
  10. When I use a word . . . The mind’s eye—phantasia, aphantasia, and hyperphantasiaBMJ · 2026
  11. Revisiting the diagnostic classification for low back painBMJ · 2026
  12. Summary of WHO clinical practice guidelines for influenzaBMJ · 2026
  13. Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based studyBMJ · 2026
  14. Evidence based mental health interventions for children in fragile and conflict affected settings: expanding reach and system strengtheningBMJ · 2026
  15. SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocolsBMJ · 2026
  16. CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trialsBMJ · 2026
  17. Long term effects of childhood exposure to violence in fragile and conflict affected settingsBMJ · 2026
  18. SPIRIT-C 2026 explanation and elaboration: recommendations for enhancing the reporting and usefulness of paediatric randomised trial protocolsBMJ · 2026
  19. Tackling the global hypertension crisisBMJ · 2026
  20. Women’s health is being targeted by authoritarian governments in Latin AmericaBMJ · 2026
  21. Psychedelic medicine: mechanisms, evidence, and translation to practiceBMJ · 2026
  22. Understanding the NHS pension: what do doctors need to know?BMJ · 2026
  23. UKRI changes explained: an upheaval in priorities and a “pause” in funding applicationsBMJ · 2026
  24. Integrating child mental health responses into recovery, development, and peacebuilding in fragile and conflict affected settingsBMJ · 2026
  25. Child and caregiver mental health in conflict affected settingsBMJ · 2026
  26. CONSORT-C 2026 explanation and elaboration: recommendations for enhancing the reporting and impact of paediatric randomised trialsBMJ · 2026
  27. Making trials in children and adolescents count: why CONSORT-C mattersBMJ · 2026
  28. Boys at risk of radicalisation must be approached with compassion, not suspicionBMJ · 2026
  29. Identifying prior evidence for new trials (REVEAL): guidance for clinical researchersBMJ · 2026
  30. MyChart: doctors are left frustrated and patients panic as NHS trusts roll out hospital records appBMJ · 2026
  31. Unpaid overtime in the NHS is falling—what this means for the workforceBMJ · 2026
  32. Abdosamad TaghizadehBMJ · 2026
  33. WHO Pandemic Agreement is only the beginning: strengthening implementation to protect global healthBMJ · 2026
  34. Taking the guesswork out of clinical trial registration informationBMJ · 2026
  35. Menopausal hormone therapy and long term mortality: nationwide, register based cohort studyBMJ · 2026
  36. Analysis of non-prospective trial registration in clinical trials submitted to The BMJ : observational studyBMJ · 2026
  37. Management of obsessive-compulsive disorder in adultsBMJ · 2026
  38. Vitamin D supplementation before in vitro fertilisation in women with polycystic ovary syndrome: multicentre, double blind, placebo controlled, randomised clinical trialBMJ · 2026
  39. The 49 000 staff question: how long can the NHS run on unpaid overtime?BMJ · 2026
  40. The academic arms race in medical recruitment—why being a good doctor is not always enoughBMJ · 2026
  41. Biological threats and community level approach to early detectionBMJ · 2026
  42. Clarity is needed about liability when medical AI failsBMJ · 2026
  43. How and when to use causal and associational languageBMJ · 2026
  44. Guiding causal inference research in general medical journalsBMJ · 2026
  45. Harmful effects of sexual chokingBMJ · 2026
  46. Blaming overdiagnosis fails to confront the deeper causes of children’s distressBMJ · 2026
  47. When I use a word . . . Medical emoticonsBMJ · 2026
  48. Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trialBMJ · 2026
  49. England’s national cancer plan is more of a commercial strategy than a health policyBMJ · 2026
  50. Ambition versus reality in NHS England’s medical training reviewBMJ · 2026